APP and Alzheimer disease: The essential neuroprotective role that TNFR2 exerts via the PI3K/Akt pathway is well established [7], and it has been shown that activation of the PI3K/Akt pathway inhibits BACE-1 expression in the APP/PS1 AD mouse model [42].